Agenus Newsroom

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating

Moomoo NewsDec 5 12:35 ET

Agenus Analyst Ratings

BenzingaNov 29 04:43 ET

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 27 12:31 ET

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)

TipRanksNov 25 01:15 ET

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $11

Moomoo NewsNov 19 03:40 ET

B. Riley Adjusts Agenus Price Target to $11 From $18, Maintains Buy Rating

MT NewswiresNov 18 08:50 ET

Agenus Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesNov 12 11:13 ET

Agenus Analyst Ratings

BenzingaNov 12 11:06 ET

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Cuts Target Price to $7

Moomoo NewsNov 12 10:32 ET

Agenus Analyst Ratings

BenzingaAug 14 09:30 ET

B. Riley Adjusts Price Target on Agenus to $18 From $42, Maintains Buy Rating

MT NewswiresAug 14 07:59 ET

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $18

Moomoo NewsAug 13 14:31 ET

Agenus Downgraded at Baird After FDA Feedback on Cancer Drug

Seeking AlphaJul 19 09:12 ET

HC Wainwright Downgrades Agenus to Neutral From Buy, Adjusts Price Target to $9 From $40

MT NewswiresJul 19 07:08 ET

HC Wainwright & Co. Downgrades Agenus to Neutral, Lowers Price Target to $9

BenzingaJul 18 12:38 ET

Agenus Analyst Ratings

BenzingaJul 18 12:37 ET

Agenus Analyst Ratings

BenzingaJun 28 13:31 ET

Buy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study Results

TipRanksMay 24 14:00 ET

Agenus Analyst Ratings

BenzingaMay 24 07:18 ET

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Merus (MRUS) and Iovance Biotherapeutics (IOVA)

TipRanksMay 24 06:25 ET